Velesco Pharma awarded subcontract to develop and manufacture clinical supplies for a new treatment for beta-thalassemia. Velesco Pharmaceutical Services, Inc., has been awarded a subcontract for analytical method development, manufacturing clinical supplies, and testing the stability of an investigational drug for the treatment for Beta-Thalassemia, a blood disorder that reduces the production of proteins that carry oxygen to…